Skip header and navigation

1 records – page 1 of 1.

Source
Pneumologia. 2009 Jul-Sep;58(3):177-8
Publication Type
Article
Author
Didilescu Cristian
Author Affiliation
Institutul de Pneumologie "Marius Nasta", Bucuresti. didilescu@yahoo.com
Source
Pneumologia. 2009 Jul-Sep;58(3):177-8
Language
Romanian, Rumanian, Moldovan
Publication Type
Article
Keywords
Animals
Antibodies - blood
Humans
Injections, Subcutaneous
Nicotine - immunology
Smoking Cessation - methods
Time Factors
Tobacco Use Disorder - immunology - prevention & control - therapy
Vaccination - methods
Vaccines - immunology - therapeutic use
Vaccines, Conjugate - immunology - therapeutic use
Abstract
The last decade is marked by a number of studies regarding the conception of an antinicotine vaccine. There are research studies waiting to be done (Switzerland, USA, Sweden). The principle is represented by the fact that nicotine has a small molecule which can cross the blood-brain barrier resulting in psychic effects and dependence. Vaccination against nicotine produces in the blood an amount of antibodies that prevent the nicotine from generating the feeling of pleasure when the person tries to smoke again. The research studies are advanced and the specialists are hoping to introduce the vaccine against nicotine on the market at the beginning of 2010.
PubMed ID
19817315 View in PubMed
Less detail